International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2018 - Volume 22, Number 1
View All Articles in Issue

Page(s): 55

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, penicillamine-D, chelating agent, heavy metals, rheumatoid arthritis, cystinuria, primary biliary cirrhosis, scleroderma, Wilson disease, copper poisoning, lead poisoning

Related Categories: EXCIPIENTS, FORMULATIONS, GASTROENTEROLOGY, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA	Mar/Apr 2016 Pg. 167-174
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention Stein Michael F, Parsons Eric	Jul/Aug 2003 Pg. 272-275
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 493
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2020 Pg. 407
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 46
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 490
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 149
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 42
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Allen Loyd V Jr	Jan/Feb 2020 Pg. 38-43
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 486
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Return to Top